Braxia Scientific Corp.: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario. | Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario. | ||
__INDEX__ | |||
Latest revision as of 17:38, 19 August 2022
SummaryEdit
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.